Literature DB >> 20395749

Mineralocorticoid receptors, corticosteroids and the heart: where do we stand?

Andrea D Eckhart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395749      PMCID: PMC2857982          DOI: 10.1097/HJH.0b013e3283378698

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  15 in total

1.  Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?

Authors:  Wenxia Chai; Johannes Hofland; Pieter M Jansen; Ingrid M Garrelds; René de Vries; Antoon J van den Bogaerdt; Richard A Feelders; Frank H de Jong; A H Jan Danser
Journal:  J Hypertens       Date:  2010-05       Impact factor: 4.844

Review 2.  Cardiac synthesis of aldosterone: going, going, gone...?

Authors:  John W Funder
Journal:  Endocrinology       Date:  2004-11       Impact factor: 4.736

3.  Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.

Authors:  Iris Z Jaffe; Michael E Mendelsohn
Journal:  Circ Res       Date:  2005-02-17       Impact factor: 17.367

4.  Mineralocorticoid receptors in myocardial infarction.

Authors:  Charles T Stier
Journal:  Hypertension       Date:  2009-10-19       Impact factor: 10.190

5.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

6.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

7.  Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.

Authors:  Masaru Hayashi; Takayoshi Tsutamoto; Atsuyuki Wada; Takashi Tsutsui; Chitose Ishii; Keijin Ohno; Masanori Fujii; Atsushi Taniguchi; Tomokazu Hamatani; Yoshitaka Nozato; Ken Kataoka; Naoki Morigami; Masato Ohnishi; Masahiko Kinoshita; Minoru Horie
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

8.  Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.

Authors:  Catherine A Lemarié; Stefania M C Simeone; Anna Nikonova; Talin Ebrahimian; Marie-Eve Deschênes; Thomas M Coffman; Pierre Paradis; Ernesto L Schiffrin
Journal:  Circ Res       Date:  2009-09-17       Impact factor: 17.367

9.  Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction.

Authors:  Anastasia S Mihailidou; Thi Yen Loan Le; Mahidi Mardini; John W Funder
Journal:  Hypertension       Date:  2009-10-19       Impact factor: 10.190

10.  Origin of aldosterone in the rat heart.

Authors:  Elise P Gomez-Sanchez; Naveed Ahmad; Damian G Romero; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2004-08-12       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.